ArticleIntestinal research2019
Ustekinumab is effective in biological refractory Crohn's disease patients-regardless of approval study selection criteria.
Sadik Saman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this paperpooled itcites it